{"transactions":[{"id":4639564,"issuer":{"id":6838,"kind":"organization","name":"Rallybio Corp","symbol":"RLYB"},"owners":[{"id":1063,"kind":"person","name":"Lieber Jonathan I","position":1,"cik":"0001350090","reported_name":"Lieber Jonathan I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option (Right to Buy)","published_at":"2026-10-13T20:50:08.000Z","date":"2026-10-09","kind":"exercise","planned":false,"acquired":false,"shares":3910,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is granted under the Company's 2021 Equity Incentive Plan. The option vests in 48 equal monthly installments until fully vested on February 14, 2029."}],"balance_after":0,"derivative":{"exercise_price":6.08,"expiration_date":"2035-02-14","underlying":"Common Stock","underlying_shares":3910},"source":{"system":"sec-edgar","filing":"0001193125-26-420562","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1739410/000119312526420562/ownership.xml","form_type":"4"}},{"id":4639563,"issuer":{"id":6838,"kind":"organization","name":"Rallybio Corp","symbol":"RLYB"},"owners":[{"id":1063,"kind":"person","name":"Lieber Jonathan I","position":1,"cik":"0001350090","reported_name":"Lieber Jonathan I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-10-13T20:50:08.000Z","date":"2026-10-09","kind":"exercise","planned":false,"acquired":true,"shares":3910,"price":6.08,"value":23772.8,"ownership":{"direct":true},"balance_after":13650,"source":{"system":"sec-edgar","filing":"0001193125-26-420562","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739410/000119312526420562/ownership.xml","form_type":"4"}},{"id":4634615,"issuer":{"id":6838,"kind":"organization","name":"Rallybio Corp","symbol":"RLYB"},"owners":[{"id":1063,"kind":"person","name":"Lieber Jonathan I","position":1,"cik":"0001350090","reported_name":"Lieber Jonathan I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option (Right to Buy)","published_at":"2026-10-02T01:32:39.000Z","date":"2026-09-29","kind":"exercise","planned":false,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is granted under the Company's 2021 Equity Incentive Plan. The option vests in 48 equal monthly installments until fully vested on February 14, 2029."}],"balance_after":0,"derivative":{"exercise_price":6.08,"expiration_date":"2035-02-14","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001193125-26-410885","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1739410/000119312526410885/ownership.xml","form_type":"4"}},{"id":4634614,"issuer":{"id":6838,"kind":"organization","name":"Rallybio Corp","symbol":"RLYB"},"owners":[{"id":1063,"kind":"person","name":"Lieber Jonathan I","position":1,"cik":"0001350090","reported_name":"Lieber Jonathan I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-10-02T01:32:39.000Z","date":"2026-09-29","kind":"exercise","planned":false,"acquired":true,"shares":5000,"price":6.08,"value":30400.0,"ownership":{"direct":true},"balance_after":9740,"source":{"system":"sec-edgar","filing":"0001193125-26-410885","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739410/000119312526410885/ownership.xml","form_type":"4"}},{"id":1274,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":1063,"kind":"person","name":"Lieber Jonathan I","position":1,"cik":"0001350090","reported_name":"Lieber Jonathan I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-02T22:32:13.000Z","date":"2026-08-31","kind":"grant","planned":false,"acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock granted under the Decoy Therapeutics Inc. 2026 Equity Incentive Plan,  100 percent will vest on August 30, 2027."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares beneficially owned following the transaction have been adjusted to reflect the reverse stock splits effective on August 15, 2025 and March 6, 2026."}],"balance_after":2002,"source":{"system":"sec-edgar","filing":"0001193125-26-380584","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1615219/000119312526380584/ownership.xml","form_type":"4"}},{"id":888159,"issuer":{"id":6838,"kind":"organization","name":"Rallybio Corp","symbol":"RLYB"},"owners":[{"id":1063,"kind":"person","name":"Lieber Jonathan I","position":1,"cik":"0001350090","reported_name":"Lieber Jonathan I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-23T23:21:32.000Z","date":"2026-02-23","kind":"sale","planned":false,"acquired":false,"shares":789,"price":5.06,"value":3992.34,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person sold shares of common stock upon the partial vesting of a performance stock award, solely to satisfy tax withholding obligations incurred upon vesting."}],"balance_after":4115,"source":{"system":"sec-edgar","filing":"0001739410-26-000022","document":"wk-form4_1771888890.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1739410/000173941026000022/wk-form4_1771888890.xml","form_type":"4"}},{"id":888158,"issuer":{"id":6838,"kind":"organization","name":"Rallybio Corp","symbol":"RLYB"},"owners":[{"id":1063,"kind":"person","name":"Lieber Jonathan I","position":1,"cik":"0001350090","reported_name":"Lieber Jonathan I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-23T23:21:32.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4904,"source":{"system":"sec-edgar","filing":"0001739410-26-000022","document":"wk-form4_1771888890.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739410/000173941026000022/wk-form4_1771888890.xml","form_type":"4"}},{"id":1260089,"issuer":{"id":6838,"kind":"organization","name":"Rallybio Corp","symbol":"RLYB"},"owners":[{"id":1063,"kind":"person","name":"Lieber Jonathan I","position":1,"cik":"0001350090","reported_name":"Lieber Jonathan I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option (Right to Buy)","published_at":"2025-02-20T00:27:18.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":180000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is granted under the Company's 2021 Equity Incentive Plan. The option vests in 48 equal monthly installments until fully vested on February 14, 2029."}],"balance_after":180000,"derivative":{"exercise_price":0.76,"expiration_date":"2035-02-14","underlying":"Common Stock","underlying_shares":180000},"source":{"system":"sec-edgar","filing":"0001739410-25-000012","document":"wk-form4_1740011231.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739410/000173941025000012/wk-form4_1740011231.xml","form_type":"4"}},{"id":1625104,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":1063,"kind":"person","name":"Lieber Jonathan I","position":1,"cik":"0001350090","reported_name":"Lieber Jonathan I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-02-22T16:21:15.000Z","date":"2024-02-20","kind":"grant","planned":false,"acquired":true,"shares":20500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":20500,"derivative":{"exercise_price":0.5711,"exercise_date":"2025-02-20","expiration_date":"2034-02-19","underlying":"Common Stock","underlying_shares":20500},"source":{"system":"sec-edgar","filing":"0001615219-24-000009","document":"wk-form4_1708636836.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1350090/000161521924000009/wk-form4_1708636836.xml","form_type":"4"}},{"id":1638341,"issuer":{"id":6838,"kind":"organization","name":"Rallybio Corp","symbol":"RLYB"},"owners":[{"id":1063,"kind":"person","name":"Lieber Jonathan I","position":1,"cik":"0001350090","reported_name":"Lieber Jonathan I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option (Right to Buy)","published_at":"2024-02-16T23:20:24.000Z","date":"2024-02-15","kind":"grant","planned":false,"acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is granted under the Company's 2021 Equity Incentive Plan. The option vests in 48 equal monthly installments until fully vested on February 15, 2028."}],"balance_after":120000,"derivative":{"exercise_price":1.86,"expiration_date":"2034-02-15","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001739410-24-000018","document":"wk-form4_1708125606.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739410/000173941024000018/wk-form4_1708125606.xml","form_type":"4"}},{"id":1950115,"issuer":{"id":6838,"kind":"organization","name":"Rallybio Corp","symbol":"RLYB"},"owners":[{"id":1063,"kind":"person","name":"Lieber Jonathan I","position":1,"cik":"0001350090","reported_name":"Lieber Jonathan I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-03-16T23:16:36.000Z","date":"2023-03-14","kind":"purchase","acquired":true,"shares":5000,"price":5.21,"value":26050.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.17 to $5.24, inclusive. The reporting person undertakes to provide to Rallybio Corporation, any security holder of Rallybio Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0000950170-23-008553","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739410/000095017023008553/ownership.xml","form_type":"4"}},{"id":2038593,"issuer":{"id":6838,"kind":"organization","name":"Rallybio Corp","symbol":"RLYB"},"owners":[{"id":1063,"kind":"person","name":"Lieber Jonathan I","position":1,"cik":"0001350090","reported_name":"Lieber Jonathan I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Option (Right to Buy)","published_at":"2023-02-01T23:33:59.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":240000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 25% of the underlying shares of Common Stock on February 1, 2024 and as to the remaining 75% of the underlying shares of Common Stock in 36 equal monthly installments thereafter."}],"balance_after":240000,"derivative":{"exercise_price":6.81,"expiration_date":"2033-02-01","underlying":"Common Stock","underlying_shares":240000},"source":{"system":"sec-edgar","filing":"0000899243-23-003156","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739410/000089924323003156/doc4.xml","form_type":"4"}},{"id":2062243,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":1063,"kind":"person","name":"Lieber Jonathan I","position":1,"cik":"0001350090","reported_name":"Lieber Jonathan I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-05T18:12:03.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":1440,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock granted under the Salarius Pharmaceuticals, Inc.2015 Equity Incentive Plan. 100% of the restricted stock will vest on January 2, 2024"}],"balance_after":2940,"source":{"system":"sec-edgar","filing":"0001615219-23-000015","document":"wf-form4_167296030411994.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1350090/000161521923000015/wf-form4_167296030411994.xml","form_type":"4"}},{"id":2099949,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":1063,"kind":"person","name":"Lieber Jonathan I","position":1,"cik":"0001350090","reported_name":"Lieber Jonathan I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-01T09:15:20.000Z","date":"2022-11-30","kind":"disposition_to_issuer","acquired":false,"shares":154700,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"At the effective time of the Merger, each outstanding option of the Issuer with an exercise price equal to or greater than $0.34 was cancelled without any consideration in respect of such cancelled option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"At the effective time of the Merger, each outstanding option of the Issuer with an exercise price equal to or greater than $0.34 was cancelled without any consideration in respect of such cancelled option."}],"balance_after":0,"derivative":{"exercise_price":0.4,"expiration_date":"2032-08-21","underlying":"Common Stock","underlying_shares":154700},"source":{"system":"sec-edgar","filing":"0001062993-22-023018","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1350090/000106299322023018/form4.xml","form_type":"4"}},{"id":2099948,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":1063,"kind":"person","name":"Lieber Jonathan I","position":1,"cik":"0001350090","reported_name":"Lieber Jonathan I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-01T09:15:20.000Z","date":"2022-11-30","kind":"disposition_to_issuer","acquired":false,"shares":202000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"At the effective time of the Merger, each outstanding option of the Issuer with an exercise price equal to or greater than $0.34 was cancelled without any consideration in respect of such cancelled option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"At the effective time of the Merger, each outstanding option of the Issuer with an exercise price equal to or greater than $0.34 was cancelled without any consideration in respect of such cancelled option."}],"balance_after":0,"derivative":{"exercise_price":3.3,"expiration_date":"2031-09-20","underlying":"Common Stock","underlying_shares":202000},"source":{"system":"sec-edgar","filing":"0001062993-22-023018","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1350090/000106299322023018/form4.xml","form_type":"4"}},{"id":2174847,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":1063,"kind":"person","name":"Lieber Jonathan I","position":1,"cik":"0001350090","reported_name":"Lieber Jonathan I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-08-24T20:04:46.000Z","date":"2022-08-21","kind":"grant","acquired":true,"shares":154700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option becomes exercisable in equal monthly installments over four years from the date of grant."}],"balance_after":154700,"derivative":{"exercise_price":0.4,"expiration_date":"2032-08-21","underlying":"Common Stock","underlying_shares":154700},"source":{"system":"sec-edgar","filing":"0001062993-22-018728","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1350090/000106299322018728/form4.xml","form_type":"4"}},{"id":2238972,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":1063,"kind":"person","name":"Lieber Jonathan I","position":1,"cik":"0001350090","reported_name":"Lieber Jonathan I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-08T15:12:16.000Z","date":"2022-06-07","kind":"purchase","acquired":true,"shares":37500,"price":0.1871,"value":7016.25,"ownership":{"direct":true},"balance_after":37500,"source":{"system":"sec-edgar","filing":"0001615219-22-000099","document":"wf-form4_165471551887755.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1350090/000161521922000099/wf-form4_165471551887755.xml","form_type":"4"}},{"id":2428662,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":1063,"kind":"person","name":"Lieber Jonathan I","position":1,"cik":"0001350090","reported_name":"Lieber Jonathan I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-01-21T16:10:03.000Z","date":"2022-01-20","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":30000,"derivative":{"exercise_price":0.48,"exercise_date":"2023-02-19","expiration_date":"2032-01-19","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001615219-22-000010","document":"wf-form4_164279938563168.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1350090/000161521922000010/wf-form4_164279938563168.xml","form_type":"4"}},{"id":2562959,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":1063,"kind":"person","name":"Lieber Jonathan I","position":1,"cik":"0001350090","reported_name":"Lieber Jonathan I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-09-21T21:25:56.000Z","date":"2021-09-20","kind":"grant","acquired":true,"shares":202000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option becomes exercisable for 25% of the underlying shares on the first anniversary of the grant date, and thereafter becomes exercisable for the remaining underlying shares in equal monthly installments over three years, resulting in the option being exercisable for 100% of the underlying shares on the fourth anniversary of the grant date."}],"balance_after":202000,"derivative":{"exercise_price":3.3,"expiration_date":"2031-09-20","underlying":"Common Stock","underlying_shares":202000},"source":{"system":"sec-edgar","filing":"0001273636-21-000028","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1350090/000127363621000028/edgar.xml","form_type":"4"}},{"id":2956448,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":1063,"kind":"person","name":"Lieber Jonathan I","position":1,"cik":"0001350090","reported_name":"Lieber Jonathan I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-12-04T16:59:23.000Z","date":"2020-12-02","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":30000,"derivative":{"exercise_price":0.74,"exercise_date":"2021-12-01","expiration_date":"2030-12-01","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001615219-20-000118","document":"wf-form4_160711914801088.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1350090/000161521920000118/wf-form4_160711914801088.xml","form_type":"4"}},{"id":3081584,"issuer":{"id":937,"kind":"organization","name":"Decoy Therapeutics Inc.","symbol":"DCOY"},"owners":[{"id":1063,"kind":"person","name":"Lieber Jonathan I","position":1,"cik":"0001350090","reported_name":"Lieber Jonathan I","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-07-16T08:33:50.000Z","date":"2020-07-14","kind":"grant","acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options fully vested on December 31, 2020."}],"balance_after":3000,"derivative":{"exercise_price":1.32,"expiration_date":"2030-07-13","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001615219-20-000077","document":"wf-form4_159490281747698.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1350090/000161521920000077/wf-form4_159490281747698.xml","form_type":"4"}},{"id":3798383,"issuer":{"id":5550,"kind":"organization","name":"Ocugen, Inc.","symbol":"OCGN"},"owners":[{"id":1063,"kind":"person","name":"Lieber Jonathan I","position":1,"cik":"0001350090","reported_name":"Lieber Jonathan I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-10-03T17:00:33.000Z","date":"2018-10-01","kind":"disposition_to_issuer","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"This transaction reflects the cancellation for no consideration of certain outstanding stock options to purchase common stock of the Issuer that were previously granted to the Reporting Person (the \"Cancelled Options\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The Cancelled Option was originally granted to the Reporting Person on July 2, 2015 and was to vest in full if the Issuer's Common Stock price reached $19.92 per shares or above for any consecutive sixty (60) day period within four (4) years of the date of grant."}],"balance_after":0,"derivative":{"exercise_price":6.37,"expiration_date":"2025-07-01","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000899243-18-026057","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1350090/000089924318026057/doc4.xml","form_type":"4"}},{"id":3798382,"issuer":{"id":5550,"kind":"organization","name":"Ocugen, Inc.","symbol":"OCGN"},"owners":[{"id":1063,"kind":"person","name":"Lieber Jonathan I","position":1,"cik":"0001350090","reported_name":"Lieber Jonathan I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-10-03T17:00:33.000Z","date":"2018-10-01","kind":"grant","acquired":true,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") that became effective on October 1, 2018. Pursuant to the Option Repricing, the exercise price of each \"Relevant Option\" (any stock option awarded by the Issuer under it 2012 Equity Incentive Plan or 2013 Equity Incentive Plan with an exercise price greater than $ 0.75628 per share held by current service providers other than the non-employee members of the Issuer's board of directors) has been amended to reduce such exercise price to $0.568, which was the closing price of a share of the Issuer's common stock  reported on The Nasdaq Capital Market on October 1, 2018. There have been no other changes to the terms of the Relevant Options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option was originally granted to the Reporting Person on February 16, 2018.  This option vests over four (4) years of service to the Issuer following February 16, 2018, with twenty-five percent (25%) vesting upon completion of one (1) year of continuous service to the Issuer following such date and the balance vesting in thirty-six (36) equal monthly installments thereafter."}],"balance_after":130000,"derivative":{"exercise_price":0.568,"expiration_date":"2028-02-15","underlying":"Common Stock","underlying_shares":130000},"source":{"system":"sec-edgar","filing":"0000899243-18-026057","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1350090/000089924318026057/doc4.xml","form_type":"4"}},{"id":3798381,"issuer":{"id":5550,"kind":"organization","name":"Ocugen, Inc.","symbol":"OCGN"},"owners":[{"id":1063,"kind":"person","name":"Lieber Jonathan I","position":1,"cik":"0001350090","reported_name":"Lieber Jonathan I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-10-03T17:00:33.000Z","date":"2018-10-01","kind":"disposition_to_issuer","acquired":false,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") that became effective on October 1, 2018. Pursuant to the Option Repricing, the exercise price of each \"Relevant Option\" (any stock option awarded by the Issuer under it 2012 Equity Incentive Plan or 2013 Equity Incentive Plan with an exercise price greater than $ 0.75628 per share held by current service providers other than the non-employee members of the Issuer's board of directors) has been amended to reduce such exercise price to $0.568, which was the closing price of a share of the Issuer's common stock  reported on The Nasdaq Capital Market on October 1, 2018. There have been no other changes to the terms of the Relevant Options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option was originally granted to the Reporting Person on February 16, 2018.  This option vests over four (4) years of service to the Issuer following February 16, 2018, with twenty-five percent (25%) vesting upon completion of one (1) year of continuous service to the Issuer following such date and the balance vesting in thirty-six (36) equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":2.63,"expiration_date":"2028-02-15","underlying":"Common Stock","underlying_shares":130000},"source":{"system":"sec-edgar","filing":"0000899243-18-026057","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1350090/000089924318026057/doc4.xml","form_type":"4"}},{"id":3798380,"issuer":{"id":5550,"kind":"organization","name":"Ocugen, Inc.","symbol":"OCGN"},"owners":[{"id":1063,"kind":"person","name":"Lieber Jonathan I","position":1,"cik":"0001350090","reported_name":"Lieber Jonathan I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-10-03T17:00:33.000Z","date":"2018-10-01","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") that became effective on October 1, 2018. Pursuant to the Option Repricing, the exercise price of each \"Relevant Option\" (any stock option awarded by the Issuer under it 2012 Equity Incentive Plan or 2013 Equity Incentive Plan with an exercise price greater than $ 0.75628 per share held by current service providers other than the non-employee members of the Issuer's board of directors) has been amended to reduce such exercise price to $0.568, which was the closing price of a share of the Issuer's common stock  reported on The Nasdaq Capital Market on October 1, 2018. There have been no other changes to the terms of the Relevant Options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option was originally granted to the Reporting Person on February 14, 2017, This option vests over four (4) years of service to the Issuer following February 14, 2017, with twenty-five percent (25%) vesting upon completion of one (1) year of continuous service to the Issuer following such date and the balance vesting in thirty-six (36) equal monthly installments thereafter."}],"balance_after":50000,"derivative":{"exercise_price":0.568,"expiration_date":"2027-02-13","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000899243-18-026057","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1350090/000089924318026057/doc4.xml","form_type":"4"}},{"id":3798379,"issuer":{"id":5550,"kind":"organization","name":"Ocugen, Inc.","symbol":"OCGN"},"owners":[{"id":1063,"kind":"person","name":"Lieber Jonathan I","position":1,"cik":"0001350090","reported_name":"Lieber Jonathan I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-10-03T17:00:33.000Z","date":"2018-10-01","kind":"disposition_to_issuer","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") that became effective on October 1, 2018. Pursuant to the Option Repricing, the exercise price of each \"Relevant Option\" (any stock option awarded by the Issuer under it 2012 Equity Incentive Plan or 2013 Equity Incentive Plan with an exercise price greater than $ 0.75628 per share held by current service providers other than the non-employee members of the Issuer's board of directors) has been amended to reduce such exercise price to $0.568, which was the closing price of a share of the Issuer's common stock  reported on The Nasdaq Capital Market on October 1, 2018. There have been no other changes to the terms of the Relevant Options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option was originally granted to the Reporting Person on February 14, 2017, This option vests over four (4) years of service to the Issuer following February 14, 2017, with twenty-five percent (25%) vesting upon completion of one (1) year of continuous service to the Issuer following such date and the balance vesting in thirty-six (36) equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":1.72,"expiration_date":"2027-02-13","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000899243-18-026057","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1350090/000089924318026057/doc4.xml","form_type":"4"}},{"id":3798378,"issuer":{"id":5550,"kind":"organization","name":"Ocugen, Inc.","symbol":"OCGN"},"owners":[{"id":1063,"kind":"person","name":"Lieber Jonathan I","position":1,"cik":"0001350090","reported_name":"Lieber Jonathan I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-10-03T17:00:33.000Z","date":"2018-10-01","kind":"grant","acquired":true,"shares":28000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") that became effective on October 1, 2018. Pursuant to the Option Repricing, the exercise price of each \"Relevant Option\" (any stock option awarded by the Issuer under it 2012 Equity Incentive Plan or 2013 Equity Incentive Plan with an exercise price greater than $ 0.75628 per share held by current service providers other than the non-employee members of the Issuer's board of directors) has been amended to reduce such exercise price to $0.568, which was the closing price of a share of the Issuer's common stock  reported on The Nasdaq Capital Market on October 1, 2018. There have been no other changes to the terms of the Relevant Options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option was originally granted to the Reporting Person on February 26, 2016. This option vests over four (4) years of service to the Issuer following February 26, 2016, with twenty-five percent (25%) vesting upon completion of one (1) year of continuous service to the Issuer following such date and the balance vesting in thirty-six (36) equal monthly installments thereafter."}],"balance_after":28000,"derivative":{"exercise_price":0.568,"expiration_date":"2026-02-25","underlying":"Common Stock","underlying_shares":28000},"source":{"system":"sec-edgar","filing":"0000899243-18-026057","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1350090/000089924318026057/doc4.xml","form_type":"4"}},{"id":3798377,"issuer":{"id":5550,"kind":"organization","name":"Ocugen, Inc.","symbol":"OCGN"},"owners":[{"id":1063,"kind":"person","name":"Lieber Jonathan I","position":1,"cik":"0001350090","reported_name":"Lieber Jonathan I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-10-03T17:00:33.000Z","date":"2018-10-01","kind":"disposition_to_issuer","acquired":false,"shares":28000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") that became effective on October 1, 2018. Pursuant to the Option Repricing, the exercise price of each \"Relevant Option\" (any stock option awarded by the Issuer under it 2012 Equity Incentive Plan or 2013 Equity Incentive Plan with an exercise price greater than $ 0.75628 per share held by current service providers other than the non-employee members of the Issuer's board of directors) has been amended to reduce such exercise price to $0.568, which was the closing price of a share of the Issuer's common stock  reported on The Nasdaq Capital Market on October 1, 2018. There have been no other changes to the terms of the Relevant Options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option was originally granted to the Reporting Person on February 26, 2016. This option vests over four (4) years of service to the Issuer following February 26, 2016, with twenty-five percent (25%) vesting upon completion of one (1) year of continuous service to the Issuer following such date and the balance vesting in thirty-six (36) equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":2.56,"expiration_date":"2026-02-25","underlying":"Common Stock","underlying_shares":28000},"source":{"system":"sec-edgar","filing":"0000899243-18-026057","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1350090/000089924318026057/doc4.xml","form_type":"4"}},{"id":3798376,"issuer":{"id":5550,"kind":"organization","name":"Ocugen, Inc.","symbol":"OCGN"},"owners":[{"id":1063,"kind":"person","name":"Lieber Jonathan I","position":1,"cik":"0001350090","reported_name":"Lieber Jonathan I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-10-03T17:00:33.000Z","date":"2018-10-01","kind":"grant","acquired":true,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") that became effective on October 1, 2018. Pursuant to the Option Repricing, the exercise price of each \"Relevant Option\" (any stock option awarded by the Issuer under it 2012 Equity Incentive Plan or 2013 Equity Incentive Plan with an exercise price greater than $ 0.75628 per share held by current service providers other than the non-employee members of the Issuer's board of directors) has been amended to reduce such exercise price to $0.568, which was the closing price of a share of the Issuer's common stock  reported on The Nasdaq Capital Market on October 1, 2018. There have been no other changes to the terms of the Relevant Options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option was originally granted to the Reporting Person on July 2, 2015. This option vests over four (4) years of service following July 2, 2015, with twenty-five percent (25%) vesting upon completion of one (1) year of continuous service and in thirty-six (36) equal monthly installments thereafter."}],"balance_after":110000,"derivative":{"exercise_price":0.568,"expiration_date":"2015-07-01","underlying":"Common Stock","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0000899243-18-026057","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1350090/000089924318026057/doc4.xml","form_type":"4"}},{"id":3798375,"issuer":{"id":5550,"kind":"organization","name":"Ocugen, Inc.","symbol":"OCGN"},"owners":[{"id":1063,"kind":"person","name":"Lieber Jonathan I","position":1,"cik":"0001350090","reported_name":"Lieber Jonathan I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-10-03T17:00:33.000Z","date":"2018-10-01","kind":"disposition_to_issuer","acquired":false,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein reflect a one-time stock option repricing (the \"Option Repricing\") that became effective on October 1, 2018. Pursuant to the Option Repricing, the exercise price of each \"Relevant Option\" (any stock option awarded by the Issuer under it 2012 Equity Incentive Plan or 2013 Equity Incentive Plan with an exercise price greater than $ 0.75628 per share held by current service providers other than the non-employee members of the Issuer's board of directors) has been amended to reduce such exercise price to $0.568, which was the closing price of a share of the Issuer's common stock  reported on The Nasdaq Capital Market on October 1, 2018. There have been no other changes to the terms of the Relevant Options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option was originally granted to the Reporting Person on July 2, 2015. This option vests over four (4) years of service following July 2, 2015, with twenty-five percent (25%) vesting upon completion of one (1) year of continuous service and in thirty-six (36) equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":6.37,"expiration_date":"2025-07-01","underlying":"Common Stock","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0000899243-18-026057","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1350090/000089924318026057/doc4.xml","form_type":"4"}},{"id":4043928,"issuer":{"id":5550,"kind":"organization","name":"Ocugen, Inc.","symbol":"OCGN"},"owners":[{"id":1063,"kind":"person","name":"Lieber Jonathan I","position":1,"cik":"0001350090","reported_name":"Lieber Jonathan I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-02-21T16:51:13.000Z","date":"2018-02-16","kind":"grant","acquired":true,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests over four (4) years of service to the Issuer following February 16, 2018, with twenty-five percent (25%) vesting upon completion of one (1) year of continuous service to the Issuer following such date and the balance vesting in thirty-six (36) equal monthly installments thereafter."}],"balance_after":130000,"derivative":{"exercise_price":2.63,"expiration_date":"2028-02-15","underlying":"Common Stock","underlying_shares":130000},"source":{"system":"sec-edgar","filing":"0000899243-18-004812","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1350090/000089924318004812/doc4.xml","form_type":"4"}},{"id":4445373,"issuer":{"id":5550,"kind":"organization","name":"Ocugen, Inc.","symbol":"OCGN"},"owners":[{"id":1063,"kind":"person","name":"Lieber Jonathan I","position":1,"cik":"0001350090","reported_name":"Lieber Jonathan I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-02-15T18:00:22.000Z","date":"2017-02-14","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests over four (4) years of service to the Issuer following February 14, 2017, with twenty-five percent (25%) vesting upon completion of one (1) year of continuous service to the Issuer following such date and the balance vesting in thirty-six (36) equal monthly installments thereafter."}],"balance_after":50000,"derivative":{"exercise_price":1.72,"expiration_date":"2027-02-14","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000899243-17-004239","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1350090/000089924317004239/doc4.xml","form_type":"4"}},{"id":4535112,"issuer":{"id":5550,"kind":"organization","name":"Ocugen, Inc.","symbol":"OCGN"},"owners":[{"id":1063,"kind":"person","name":"Lieber Jonathan I","position":1,"cik":"0001350090","reported_name":"Lieber Jonathan I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2016-12-02T17:00:34.000Z","date":"2016-12-02","kind":"purchase","acquired":true,"shares":5000,"price":1.9461,"value":9730.5,"ownership":{"direct":true},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0000899243-16-034849","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1350090/000089924316034849/doc4.xml","form_type":"4"}}]}